$LCII
LCI INDUSTRIES Stock $lcii

$lcii Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000076374424000059 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$1.055B	$968.0M
YoY Change	3.93%	-0.54%
Cost Of Revenue	$788.1M	$744.1M
YoY Change	-1.06%	-5.48%
Gross Profit	$266.4M	$223.9M
YoY Change	22.16%	20.33%
Gross Profit Margin	25.27%	23.13%
Selling, General & Admin	$175.8M	$166.3M
YoY Change	7.91%	0.16%
% of Gross Profit	66.0%	74.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$32.04M	$32.69M
YoY Change	-3.06%	0.58%
% of Gross Profit	12.02%	14.6%
Operating Expenses	$175.8M	$166.3M
YoY Change	7.91%	0.16%
Operating Profit	$90.60M	$57.61M
YoY Change	64.22%	187.44%
Interest Expense	-$7.962M	-$9.321M
YoY Change	-22.31%	-10.32%
% of Operating Profit	-8.79%	-16.18%
Other Income/Expense, Net
YoY Change
Pretax Income	$82.64M	$48.29M
YoY Change	83.96%	400.47%
Income Tax	$21.48M	$11.75M
% Of Pretax Income	25.99%	24.32%
Net Earnings	$61.16M	$36.55M
YoY Change	82.98%	403.44%
Net Earnings / Revenue	5.8%	3.78%
Basic Earnings Per Share	$2.40	$1.44
Diluted Earnings Per Share	$2.40	$1.44
COMMON SHARES
Basic Shares Outstanding	25.45M shares	25.33M shares
Diluted Shares Outstanding	25.50M shares	25.39M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$130.4M	$22.63M
YoY Change	490.29%	-3.58%
Cash & Equivalents	$130.4M	$22.63M
Short-Term Investments
Other Short-Term Assets	$67.64M	$68.07M
YoY Change	-19.15%	-25.71%
Inventory	$687.9M	$734.4M
Prepaid Expenses
Receivables	$333.1M	$344.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.219B	$1.169B
YoY Change	-1.32%	-14.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$448.0M	$454.1M
YoY Change	-6.44%	-5.58%
Goodwill	$588.5M	$587.8M
YoY Change	0.72%	3.82%
Intangibles	$421.7M	$432.7M
YoY Change	-11.65%	-11.94%
Long-Term Investments
YoY Change
Other Assets	$94.92M	$94.85M
YoY Change	59.53%	64.9%
Total Long-Term Assets	$1.793B	$1.812B
YoY Change	-2.62%	-1.77%
TOTAL ASSETS
Total Short-Term Assets	$1.219B	$1.169B
Total Long-Term Assets	$1.793B	$1.812B
Total Assets	$3.012B	$2.981B
YoY Change	-2.09%	-7.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$202.6M	$193.9M
YoY Change	10.94%	14.16%
Accrued Expenses	$190.7M	$177.2M
YoY Change	-2.78%	-13.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$558.0K	$568.0K
YoY Change	-97.99%	-97.77%
Total Short-Term Liabilities	$432.5M	$409.0M
YoY Change	-2.03%	-6.19%
LONG-TERM LIABILITIES
Long-Term Debt	$829.2M	$854.8M
YoY Change	-9.45%	-19.03%
Other Long-Term Liabilities	$112.1M	$111.2M
YoY Change	8.4%	8.64%
Total Long-Term Liabilities	$941.3M	$966.0M
YoY Change	-7.64%	-16.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$432.5M	$409.0M
Total Long-Term Liabilities	$941.3M	$966.0M
Total Liabilities	$1.618B	$1.624B
YoY Change	-5.16%	-12.18%
SHAREHOLDERS EQUITY
Retained Earnings	$1.220B	$1.186B
YoY Change	1.03%	-1.26%
Common Stock	$247.3M	$241.8M
YoY Change	4.87%	4.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$82.22M	$82.22M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$1.394B	$1.357B
YoY Change
Total Liabilities & Shareholders Equity	$3.012B	$2.981B
YoY Change	-2.09%	-7.11%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$61.16M	$36.55M
YoY Change	82.98%	403.44%
Depreciation, Depletion And Amortization	$32.04M	$32.69M
YoY Change	-3.06%	0.58%
Cash From Operating Activities	$192.9M	-$7.654M
YoY Change	-2.99%	-110.25%
INVESTING ACTIVITIES
Capital Expenditures	$12.72M	$8.608M
YoY Change	-24.84%	-49.83%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$19.58M	-$173.0K
YoY Change	13.71%	-91.17%
Cash From Investing Activities	-$32.30M	-$8.435M
YoY Change	-5.4%	-60.67%
FINANCING ACTIVITIES
Cash Dividend Paid		$26.72M
YoY Change		0.59%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-52.65M	-$26.45M
YoY Change	-68.38%	-65.57%
NET CHANGE
Cash From Operating Activities	192.9M	-$7.654M
Cash From Investing Activities	-32.30M	-$8.435M
Cash From Financing Activities	-52.65M	-$26.45M
Net Change In Cash	108.0M	-$43.53M
YoY Change	-6285.11%	81.13%
FREE CASH FLOW
Cash From Operating Activities	$192.9M	-$7.654M
Capital Expenditures	$12.72M	$8.608M
Free Cash Flow	$180.2M	-$16.26M
YoY Change	-0.96%	-128.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	744123000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	787239000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	223906000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	186071000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	166295000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	166028000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	57611000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	20043000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9321000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10394000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	48290000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9649000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11745000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2390000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36545000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.44
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25374000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25228000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25389000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25293000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36545000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7259000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3263000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	33282000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9259000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22625000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66157000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7181000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5701000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	344406000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	214707000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	734360000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	768407000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68068000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	67599000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1169459000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1116870000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454071000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	465781000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	587791000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	589550000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	432728000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	448759000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	242442000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	245388000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94845000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	92971000	usd
CY2024Q1	us-gaap	Assets Assets	2981336000	usd
CY2023Q4	us-gaap	Assets Assets	2959319000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	568000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	589000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	193933000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	183697000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37322000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36269000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	177217000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	174437000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	409040000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	394992000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	854774000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	846834000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	218236000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	222680000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	31211000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	32345000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	111191000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107432000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1624452000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1604283000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	288000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	287000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	241514000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	245659000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1186289000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1177034000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11009000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14272000	usd
CY2024Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	1439100000	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	1437252000	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	82216000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	82216000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1356884000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1355036000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2981336000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2959319000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36545000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7259000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32689000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32499000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4327000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4695000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1107000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-877000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	131059000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	123072000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-32892000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-131708000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2392000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5577000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	12038000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	25822000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6199000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10689000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7654000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74676000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8608000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17159000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6250000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-173000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1960000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8435000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21449000	usd
CY2024Q1	lcii	Proceedsfrom Issuanceof Sharesunder Incentiveand Sharebased Compensation Plans Including Stock Options Netof Payments Relatedto Tax Withholdingfor Sharebased Compensation ProceedsfromIssuanceofSharesunderIncentiveandSharebasedCompensationPlansIncludingStockOptionsNetofPaymentsRelatedtoTaxWithholdingforSharebasedCompensation	-9040000	usd
CY2023Q1	lcii	Proceedsfrom Issuanceof Sharesunder Incentiveand Sharebased Compensation Plans Including Stock Options Netof Payments Relatedto Tax Withholdingfor Sharebased Compensation ProceedsfromIssuanceofSharesunderIncentiveandSharebasedCompensationPlansIncludingStockOptionsNetofPaymentsRelatedtoTaxWithholdingforSharebasedCompensation	-8888000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	86248000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	165300000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	76927000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	201385000	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	5000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	5276000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	26721000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	26563000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-12000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26447000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76824000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-996000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-437000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43532000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24034000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66157000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47499000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22625000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23465000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	7391000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	9052000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	359000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	390000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	407000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2304000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1381008000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7259000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	119091	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-8888000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4695000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2023Q1	us-gaap	Dividends Cash DividendsCash	26563000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1359511000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1355036000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36545000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	122023	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-9040000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4327000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3263000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2024Q1	us-gaap	Dividends Cash DividendsCash	26721000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1356884000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	589550000	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1759000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	587791000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to product returns, sales and purchase rebates, accounts receivable, inventories, goodwill and other intangible assets, net assets of acquired businesses, income taxes, warranty and product recall obligations, self-insurance obligations, operating lease right-of-use assets and obligations, asset retirement obligations, long-lived assets, pension and post-retirement benefits, stock-based compensation, segment allocations, contingent consideration, environmental liabilities, contingencies, and litigation. The Company bases its estimates on historical experience, other available information, and various other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other resources. Actual results and events could differ significantly from management estimates.</span></div>
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25374000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25228000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	65000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25389000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25293000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	291000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	160000	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2800000	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	259.84
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	259.84
CY2021Q2	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	100100000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	739880000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	307152000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	432728000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	742048000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	293289000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	448759000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	427320000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	457877000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	43688000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	45112000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	263352000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	265418000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	734360000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	768407000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	76100000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	71300000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	986971000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	983548000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	532900000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	517767000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454071000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	465781000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	568000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	589000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	854774000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	846834000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	58183000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	58999000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	46725000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	48468000	usd
CY2024Q1	lcii	Sales Rebates Accrual Current SalesRebatesAccrualCurrent	20697000	usd
CY2023Q4	lcii	Sales Rebates Accrual Current SalesRebatesAccrualCurrent	19403000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51612000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47567000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	177217000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	174437000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	71578000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	54528000	usd
CY2024Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	13123000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	20827000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	14586000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	15227000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	70115000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	60128000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	23390000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	19770000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	46725000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	40358000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5868000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6624000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	855342000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	847423000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	15688000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	15244000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	987000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1480000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	886000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1000000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	17561000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	17724000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28789000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28667000	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3341000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3341000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25448000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25326000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	4.20
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.05
CY2022Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	200000000	shares
CY2022Q2	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	253490	shares
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	94.89
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	24100000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q1	us-gaap	Revenues Revenues	968029000	usd
CY2023Q1	us-gaap	Revenues Revenues	973310000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	57611000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	20043000	usd
CY2024Q1	us-gaap	Revenues Revenues	968029000	usd
CY2023Q1	us-gaap	Revenues Revenues	973310000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0000763744-24-000059-index-headers.html	Edgar Link	pending
0000763744-24-000059-index.html	Edgar Link	pending
0000763744-24-000059.txt	Edgar Link	pending
0000763744-24-000059-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lcii-03312024xex101xformof.htm	Edgar Link	pending
lcii-03312024xex311.htm	Edgar Link	pending
lcii-03312024xex312.htm	Edgar Link	pending
lcii-03312024xex321.htm	Edgar Link	pending
lcii-03312024xex322.htm	Edgar Link	pending
lcii-20240331.htm	Edgar Link	pending
lcii-20240331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lcii-20240331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
lcii-20240331_def.xml	Edgar Link	unprocessable
lcii-20240331_htm.xml	Edgar Link	completed
lcii-20240331_lab.xml	Edgar Link	unprocessable
lcii-20240331_pre.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lcii-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCII
LCI INDUSTRIES Stock $lcii

2024 Q2 Form 10-Q Financial Statement

#000076374424000059 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCII LCI INDUSTRIES Stock $lcii

2024 Q2 Form 10-Q Financial Statement

#000076374424000059 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCII
LCI INDUSTRIES Stock $lcii